Alzamend Neuro, Inc.
ALZN · XNASCIK 1677077fmd_07YJA2TYX16T8AWKNWNRMNMZ3YManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: May 01, 2019 to Jul 31, 2026, 27 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading